clodronic acid has been researched along with Fabry Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cheng, SH; Cherry, M; Desnick, RJ; Goldberg, MA; Hempel, D; Ioannou, YA; Li, C; van Rooijen, N; Yew, NS; Zhu, Y; Ziegler, RJ | 1 |
1 other study(ies) available for clodronic acid and Fabry Disease
Article | Year |
---|---|
Correction of the nonlinear dose response improves the viability of adenoviral vectors for gene therapy of Fabry disease.
Topics: Adenoviridae; alpha-Galactosidase; Animals; Clodronic Acid; Dose-Response Relationship, Drug; Fabry Disease; Female; gamma-Globulins; Genetic Therapy; Genetic Vectors; Humans; Kupffer Cells; Liver; Mice; Mice, Inbred BALB C; Transduction, Genetic | 2002 |